22nd February 2017

As high-purity/high-dose ecstasy pills return to the market and casualties rise, Oli Stevens discusses the roles testing can play. It can act as a harm reduction initiative, can it shape the composition of drug markets themselves?

13th September 2016

The recent deaths at Fabric were tragic, and more will follow them if we do not embrace receational drug harm reduction measures.

5th January 2015

14th March 2014